Evaluation of the role of hydroxychloroquine as a lipid profile improving and glucose adjusting drug in Egyptian females with inactive rheumatoid arthritis
Background/aim Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease that leads to joint destruction and disability with increased risk of cardiovascular disease (CVD), a leading cause of morbidity and mortality in RA. Modifying CVD risk factors, such as lowering plasma glucose and to...
Saved in:
Main Authors: | Aliaa O. El-Hady, Mai M. Kamel, Yasmin T. Mosaad, Maha A. Ali, Soad S. El Molla |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-12-01
|
Series: | Journal of the Arab Society for Medical Research |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/jasmr.jasmr_5_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Innovative Lipid Nanoparticles Co-Delivering Hydroxychloroquine and siRNA for Enhanced Rheumatoid Arthritis Therapy
by: Yanru Feng, et al.
Published: (2025-01-01) -
Liposomal Formulation of Hydroxychloroquine Can Inhibit Autophagy In Vivo
by: Wieslawa H. Dragowska, et al.
Published: (2024-12-01) -
Early detection of the retinal bioelectrical dysfunction in patients treated by chloroquine/hydroxychloroquine
by: Wojciech Lubiński, et al.
Published: (2024-12-01) -
A study of serum YKL-40 and its correlation with traditional biomarkers in rheumatoid arthritis patients
by: Vinod Narayan, et al.
Published: (2019-01-01) -
Physiologically-based pharmacokinetic modeling of enantioselective hydroxychloroquine kinetics and impact of genetic polymorphisms
by: Gabriella de Souza Gomes Ribeiro, et al.
Published: (2025-01-01)